Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk.
Clinical aspects of symptomatic hyponatremia.
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.
Money Management Activities in Persons with Multiple Sclerosis.
Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy.
Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk.
Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis.
Expanding the range of immunopathology in neuromyelitis optica spectrum disorder.
Addition of a general surgeon without addition of appropriate support is inadequate to improve outcomes of trauma patients in a rural setting: a cohort study of 1962 consecutive patients.
Magnetic resonance imaging assessment of degenerative cervical myelopathy: a review of structural changes and measurement techniques.
Thickening of the peripheral nerves in metachromatic leukodystrophy.
SOX10 Regulates an Alternative Promoter at the Charcot-Marie-Tooth Disease Locus MTMR2.
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.
Dysautonomic polyneuropathy as a variant of chronic inflammatory "demyelinating" polyneuropathy?
Assessment of vitamin D status - a changing landscape.
Corrigendum to "The-effect-of-triiodothyronine-on-maturation-and-differentiation-of-oligodendrocyte-progenitor-cells-during-remyelination-following-induced-demyelination in male albino rat" [Tissue Cell 48 (March (3)) (2016) 242-251].
Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.
Metabolic Patterns in Chronic MS Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using Two-Dimensional MR Spectroscopic Imaging.
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NFκB.
Which gait parameter can be used to evaluate gait improvement in multiple sclerosis?
Antibodies in multiple sclerosis oligoclonal bands target debris.
Lesson of the month 1: Post-malaria neurological syndromes.
Patients smoking cannabis are risking their health.
Medical cannabis - the Canadian perspective.
Pages
« first
‹ previous
…
765
766
767
768
769
770
771
772
773
…
next ›
last »